REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: China Threatens Retaliation Over Hong Kong Bill

Thu, 21st Nov 2019 12:03

(Alliance News) - Stock prices in London were lower at midday on Thursday after US lawmakers passed a bill supporting Hong Kong's rights, potentially putting US-China trade progress in jeopardy.

US lawmakers took the last step to approve legislation supporting protesters in Hong Kong in an almost unanimous vote on Wednesday, before sending it on to President Donald Trump for a signature.

China on Thursday accused the US of seeking to "destroy" Hong Kong and threatened retaliation after Congress passed new legislation supporting the pro-democracy movement that has thrown the city into nearly six months of turmoil.

Foreign Minister Wang Yi said the passage of the Hong Kong Human Rights & Democracy Act "indulges violent criminals" which China blames for the worsening unrest and aims to "muddle or even destroy Hong Kong".

In addition, a foreign ministry spokesman vowed that China would "take effective measures to resolutely fight back", giving no details.

The FTSE 100 was down 48.62 points, or 0.7%, at 7,213.87. The FTSE 250 was down 152.57 points, or 0.8%, at 20,322.68, but the AIM All-Share was up 1.42 points, or 0.1%, at 900.74.

The Cboe UK 100 index was down 0.6% at 12,236.62. The Cboe UK 250 was down 0.8% at 18,262.07, and the Cboe UK Small Companies was flat at 11,313.71.

In Paris the CAC 40 was down 0.3%, while the DAX 30 in Frankfurt was down 0.2%.

"Trump's likely signing of the Hong Kong bill raises the prospect that the US and China will find something other than trade to quarrel over - if the president was looking for an excuse to renew their trade spat then he has a tailor-made opportunity here to both hit China on trade and present himself as a champion of human rights and democracy. For someone so devoted to his public image, especially now the impeachment hearings are piling on the pressure, the opportunity may be too big to pass up," said IG Group's Chris Beauchamp.

On the London Stock Exchange, Centrica was the best blue-chip performer, up 8.0% after the British Gas owner backed annual guidance after what it said has been a "solid" second-half performance.

The utility delivered growth in customer accounts, higher margins, and returns in business energy supply in North America, it said, as well as strong trading in Europe. This has helped offset the impact of further outages at the non-operated Dungeness B and Hunterston B nuclear power stations, in Kent and North Ayrshire respectively. Nuclear operations were put up for sale earlier this year.

Centrica backed 2019 guidance of adjusted operating cash flow at the lower end of GBP1.8 billion to GBP2.0 billion, and net debt within GBP3.0 billion to GBP3.5 billion. The firm has cut capital investment guidance to GBP800 million from GBP900 million, and increased efficiency savings for the year to GBP300 million from GBP250 million.

GlaxoSmithKline was up 0.9% after UBS raised the drugmaker to Buy from Neutral.

At the other end of the large-cap index. Johnson Matthey was down 7.5% after the specialty chemical firm said interim profit was hit by problems in its Clean Air division.

Pretax profit fell 8% to GBP225 million for the half-year to September, and the underlying figure also declined by 8% to GBP231 million. The company said profit was hit by around GBP15 million of one-off costs in the Clean Air division due to higher freight costs and manufacturing inefficiencies. This, Johnson Matthey continued, stemmed from the phasing of the completion of a new plant in Poland.

Looking ahead, Johnson Matthey expects full-year performance to meet the market's expectations.

Aviva was down 1.8% after Deutsche Bank cut the insurer to Hold from Buy.

In the FTSE 250, Direct Line Insurance was the best performer, up 6.0% after the insurer late Wednesday said its third-quarter performance was encouraging.

Direct Line said its total gross written premiums for the three months to September 30 rose 0.4% to GBP858.0 million from GBP854.5 million the year before. This included a return to growth for motor to GBP457.8 million, up 0.3% from GBP456.4 million.

In terms of financial targets, Direct Line is aiming to improve its operating expense ratio to 20% by the end of 2023 so it is more sustainably competitive. In 2018, Direct Line's operating expenses came to GBP722 million, or GBP644 million before depreciation and amortisation. The company hopes to cut this GBP644 figure by over GBP50 million by 2021 to under GBP590 million.

Further, Direct Line gave details on plans for capital returns saying: "At the group's current valuation, where the regular dividend yield is materially higher than market comparators, the board's preference is to return any surplus capital, after ordinary dividends, by way of a buyback programme."

At the other end of the midcaps, Royal Mail was by far the worst performer, down 16%. The postal operator reported a significant rise in interim profit, but warned its transformation plan is off track.

Royal Mail's pretax profit for the six months to September 29 multiplied to GBP173 million from GBP33 million, though the adjusted figure was down 20% to GBP146 million. Revenue climbed by 5.2% to GBP5.17 billion.

However, Royal Mail warned the outlook for the letters business in the UK remains challenging, due to lower-than-expected UK economic growth and business uncertainty. For its current financial year, Royal Mail sees a 7% to 9% fall in addressed letter volumes, excluding the upcoming UK general election, which brings a surge of political mailings. Next year, volumes could fall between 6% to 8%.

"Royal Mail's investment case always rested heavily on the argument that years of public ownership had left the group bloated, underinvested and with lots of low hanging efficiency savings to harvest. Well that may have been true up to a point, but any low hanging fruit is long gone, and a heavily unionised workforce is making future cost savings difficult, if not impossible, to deliver. The combination of falling revenues and stubbornly high costs is stamping out the group's profit margins," commented Hargreaves Lansdown analyst Nick Hyett.

The pound was quoted at USD1.2645 at midday, up from USD1.2909 at the London equities close Wednesday, with three weeks to go until the UK general election.

On the UK political front, opposition party Labour said its manifesto would bring about "real change" to overhaul the UK's "rigged" society as it pledged to boost wages, tackle climate change and re-nationalise key utilities.

Leader Jeremy Corbyn revealed the full details of his election manifesto in a speech in Birmingham. It includes promises of free broadband for all homes and businesses by 2030 and more money for the health service.

On Brexit, the party will keep to the position decided at its autumn conference of renegotiating an exit deal with the EU by March and then putting those terms to a public vote within another three months, with Remain as an option.

The manifesto will contain intentions to significantly boost NHS spending, create a GBP10 minimum hourly wage for all, and tackle climate change by creating jobs in a "green industrial revolution".

Stocks in New York were set for a lower open with the DJIA, S&P 500 index and Nasdaq Composite all pointed down 0.1%.

US central bankers last month dismissed the idea of taking interest rates into negative territory, according to meeting minutes released on Wednesday.

Evidence for the benefits of negative interest rates - lenders must pay borrowers rather than the other way around - has proven "mixed" in countries where it has been tried, according to members of the Fed's rate-setting Federal Open Market Committee.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.